lidocaine has been researched along with Kidney Diseases in 19 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The plasma protein binding of diazepam and lidocaine was measured in patients with renal disease (those with uremia, nephrotic syndrome, or who had received a transplant) and in age- and sex- matched control subjects." | 3.66 | Diazepam and lidocaine plasma protein binding in renal disease. ( Davis, D; Grossman, SH; Kitchell, BB; Routledge, PA; Shand, DG, 1982) |
| "Sixty patients with renal colic were enrolled in this study and divided into two groups by a simple randomization: (i) the butylscopolamine group (n = 30, intravenous injection of butylscopolamine bromide and sulpyrine); and (ii) the lidocaine group (n = 30, local anesthesia to the trigger point with lidocaine)." | 2.70 | Randomized trial of trigger point injection for renal colic. ( Hayashi, T; Iguchi, M; Katoh, Y; Koike, H; Nakamura, M, 2002) |
| " In 9 with total renal failure, the plasma half-life ranged from 16." | 1.27 | Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis. ( Augustin, J; Graffner, C; Hanrath, P; Kuck, KH; Pottage, A; Runge, M; Wiegers, U, 1983) |
| " In one patient with active hepatic necrosis the terminal plasma half-life was 57." | 1.27 | Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction. ( Endell, W; Oltmanns, D; Pottage, A, 1983) |
| "The pharmacokinetic parameters of lidocaine are pertinent to the determination of both appropriate loading doses and constant infusion rates that achieve a therapeutic plasma concentration while avoiding toxicity." | 1.26 | Pharmacokinetic principles of lidocaine dosing in relation to disease state. ( Waller, ES, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iguchi, M | 1 |
| Katoh, Y | 1 |
| Koike, H | 1 |
| Hayashi, T | 1 |
| Nakamura, M | 1 |
| Laskowski, IA | 1 |
| Muhs, B | 1 |
| Rockman, CR | 1 |
| Adelman, MA | 1 |
| Ranson, M | 1 |
| Cayne, NS | 1 |
| Leivent, JA | 1 |
| Maldonado, TS | 1 |
| Wiegers, U | 1 |
| Hanrath, P | 1 |
| Kuck, KH | 1 |
| Pottage, A | 2 |
| Graffner, C | 1 |
| Augustin, J | 1 |
| Runge, M | 1 |
| Oltmanns, D | 2 |
| Endell, W | 2 |
| Pottage, T | 1 |
| Grossman, SH | 1 |
| Davis, D | 1 |
| Kitchell, BB | 1 |
| Shand, DG | 1 |
| Routledge, PA | 1 |
| Waller, ES | 1 |
| Sotaniemi, EA | 1 |
| Rautio, A | 1 |
| Bäckstrom, M | 1 |
| Arvela, P | 1 |
| Pelkonen, O | 1 |
| Azoulay, D | 1 |
| Adam, R | 1 |
| Pham, P | 1 |
| Salvucci, M | 1 |
| Davoll, S | 1 |
| Bismuth, H | 1 |
| Debuire, B | 1 |
| Lemoine, A | 1 |
| Nikiforov, S | 1 |
| Cronin, AJ | 1 |
| Murray, WB | 1 |
| Hall, VE | 1 |
| Colgan, FJ | 1 |
| Krauss, DJ | 1 |
| Khonsari, F | 1 |
| Lilien, OM | 1 |
| Ogborn, MR | 1 |
| Wood, M | 1 |
| Doherty, JE | 1 |
| Kane, JJ | 1 |
| McVicar, M | 1 |
| Nicastri, AD | 1 |
| Gauthier, B | 1 |
| Hall, DR | 1 |
| McGibbon, DH | 1 |
| Evans, CC | 1 |
| Meadows, GA | 1 |
| Kessler, KM | 1 |
| Levy, RH | 1 |
| Smith, GH | 1 |
4 reviews available for lidocaine and Kidney Diseases
| Article | Year |
|---|---|
Problems with postoperative drug therapy.
Topics: Anesthesia; Anesthetics; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Drug Therap | 1977 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
Clinical pharmacology and therapeutics use of digitalis glycosides.
Topics: Adenosine Triphosphatases; Arrhythmias, Cardiac; Digitalis Glycosides; Digitoxin; Digoxin; Heart; He | 1973 |
Individualization of dosage of antiarrhythmic drugs.
Topics: Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Heart Diseases; Humans; Ki | 1974 |
3 trials available for lidocaine and Kidney Diseases
| Article | Year |
|---|---|
Randomized trial of trigger point injection for renal colic.
Topics: Adult; Anesthetics, Local; Butylscopolammonium Bromide; Colic; Female; Humans; Injections, Intralesi | 2002 |
Regional nerve block allows for optimization of planning in the creation of arteriovenous access for hemodialysis by improving superficial venous dilatation.
Topics: Anesthetics, Local; Arm; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis Implantation; Brachi | 2007 |
Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Kidney Diseases; Lidocaine; Liver Function Te | 1997 |
12 other studies available for lidocaine and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
Topics: Aged; Female; Half-Life; Humans; Kidney Diseases; Kinetics; Lidocaine; Male; Middle Aged; Renal Dial | 1983 |
Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction.
Topics: Adult; Aged; Creatinine; Half-Life; Humans; Infusions, Parenteral; Kidney Diseases; Kinetics; Lidoca | 1983 |
Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency.
Topics: Anti-Arrhythmia Agents; Humans; Kidney Diseases; Lidocaine; Liver Diseases; Metabolic Clearance Rate | 1983 |
Diazepam and lidocaine plasma protein binding in renal disease.
Topics: Adult; Aged; Blood Proteins; Diazepam; Fatty Acids, Nonesterified; Female; Humans; Kidney Diseases; | 1982 |
Pharmacokinetic principles of lidocaine dosing in relation to disease state.
Topics: Adult; Age Factors; Aged; Animals; Dogs; Drug Therapy, Combination; Half-Life; Heart Failure; Humans | 1981 |
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
Topics: Administration, Oral; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Capsules; Coumarins; Cytochrome P- | 1995 |
Subcutaneous paravertebral block for renal colic.
Topics: Adult; Analgesia; Anesthetics, Local; Colic; Female; Humans; Kidney Diseases; Lidocaine; Nerve Block | 2001 |
Incapacitating flank pain of questionable renal origin.
Topics: Adult; Aged; Anesthesia, Local; Female; Humans; Intercostal Nerves; Kidney Diseases; Lidocaine; Male | 1977 |
The use of a eutectic mixture of local anesthetic in pediatric renal biopsy.
Topics: Administration, Topical; Adolescent; Anesthetics, Local; Biopsy; Child; Child, Preschool; Humans; Ki | 1992 |
Improved renal biopsy technique in children.
Topics: Analgesia; Biopsy; Child; Fluoroscopy; Hematoma; Hematuria; Humans; Kidney; Kidney Cortex; Kidney Di | 1974 |
Gentamicin, tubocurarine, lignocaine and neuromuscular blockade. A case report.
Topics: Aortic Valve; Drug Interactions; Gentamicins; Heart Valve Prosthesis; Humans; Kidney Diseases; Lidoc | 1972 |
Dosage regimens of antiarrhythmics. II. Applications.
Topics: Anti-Arrhythmia Agents; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Lidocaine; | 1973 |